[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Reference Listed Drug Labeling Approved in July 1999

Some of the product names below contain links to the approved labeling or the supplemental approval letter describing the specific changes.  Click on the product name to view the approved labeling changes in Adobe Acrobat format.

Product Name Drug Name

NDA No.

Supp.No

Firm

Date

VIDEX Didanosine chewable tablets

20-154

S-028

Bristol Myers Squibb

01-Jul-1999

VIDEX Didanosine for oral solution

20-155

S-020

Bristol Myers Squibb

01-Jul-1999

ZERIT Stavudine capsules

20-412

S-010

Bristol Myers Squibb

01-Jul-1999

ZERIT Stavudine oral solution

20-413

S-003

Bristol Myers Squibb

01-Jul-1999

CAVERJECT Alprostadil for injection

20-379

S-012

Pharmacia & Upjohn

02-Jul-1999

RISPERDAL Risperidone tablet

20-588

S-005

Janssen

02-Jul-1999

RISPERDAL Risperidone

20-272

S-009

Janssen

02-Jul-1999

PREVACID Lansoprazole capsule

20-406

S-028

Tap Holdings

06-Jul-1999

PRIMACOR Milrinone lactate injection

19-436

S-012

Sanofi

06-Jul-1999

PRIMACOR Milrinone lactate injection

20-343

S-008

Sanofi

06-Jul-1999

TONOCARD Tocainide HCl tablets

18-257

S-026

Astra Pharms

07-Jul-1999

AGGRASTAT Tirofiban HCl injection

20-913

S-001

Merck

09-Jul-1999

AGGRASTAT Tirofiban HCl injection

20-912

S-001

Merck

09-Jul-1999

COUMADIN Warfarin sodium tablets/injection

09-218

S-096

Dupont Merck

09-Jul-1999

REGONAL Pyridostigmine bromide

17-398

S-013

Organon

12-Jul-1999

OMNICEF Cefdinir oral suspension

50-749

S-004

Parke Davis

13-Jul-1999

KADIAN Morphine sulfate extended-release capsules

20-616

S-003

Faulding Pharm

16-Jul-1999

XALATAN Latanoprost opthalmic

20-597

S-008

Pharmacia & Upjohn

16-Jul-1999

CORTISPORIN Neomycin and polymixin B sulfates/hydrocortisone acetate cream

50-218

S-047

Monarch Pharms

19-Jul-1999

CORTISPORIN Neomycin & polymixin B sulfates/bacitracin zinc/hydrocortisone oint

50-168

S-073

Monarch Pharms

19-Jul-1999

FLOVENT Fluticasone propionate

20-549

S-006

Glaxo Wellcome

19-Jul-1999

GLUCAGON Glucagon for injection

20-928

S-001

Lilly

19-Jul-1999

PENICILLIN G Penicillin G potassium injection

50-638

S-006

Baxter Hlthcare

20-Jul-1999

ZITHROMAX Azithromycin injection

50-733

S-001

Pfizer

20-Jul-1999

INTEGRILIN Intrifiban

20-718

S-003

Cor

21-Jul-1999

TENORETIC Atenolol/chlorthalidone tablets

18-760

S-023

Zeneca Pharms

21-Jul-1999

TENORMIN Atenolol injection

19-058

S-013

Zeneca Pharms

21-Jul-1999

TENORMIN Atenolol tablets

18-240

S-026

Zeneca Pharms

21-Jul-1999

ALDORIL Methyldopa/HCTZ tablets

13-402

S-081

Merck

23-Jul-1999

TOPAMAX Topiramate tablets

20-505

S-001

Johnson RW

23-Jul-1999

TOPAMAX Topiramate capsules

20-844

S-001

Johnson RW

23-Jul-1999

LAMISIL Terbinafine emulsion gel

20-846

S-001

Novartis Pharms

26-Jul-1999

KYTRIL Granisetron HCl tablets

20-305

S-004

SKB Pharms

27-Jul-1999

TICLID Ticlopidine HCl

19-979

S-017

Syntex USA

28-Jul-1999

ANCEF Cefazolin sodium for injection

50-461

S-133

Smithkline Beecham

29-Jul-1999

BIAXIN Clarithromycin tablets

50-662

S-026

Abbott Labs

29-Jul-1999

KEFTAB Cephalexin HCl tablets

50-614

S-019

Eli Lilly

29-Jul-1999

LEVAQUIN Levofloxacin injection

20-635

S-006

Johnson Rw

29-Jul-1999

LEVAQUIN Levofloxacin tablets

20-634

S-007

Johnson Rw

29-Jul-1999

PDF requires the free Adobe Acrobat Reader

Date created: August 17, 1999; last update: July 7, 2005

horizonal rule